| Dr Martin A Morse, MD, FACS | |
|
8841 E Bell Rd Ste 201, Scottsdale, AZ 85260-1984 | |
| (703) 757-6190 | |
| (703) 757-6195 |
| Full Name | Dr Martin A Morse |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 8841 E Bell Rd Ste 201, Scottsdale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386640936 | NPI | - | NPPES |
| 7309554 | Medicaid | VA |
| Entity Name | Fitzmaurice Hand Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609112861 PECOS PAC ID: 1254571714 Enrollment ID: O20130703000312 |
News Archive
When bedbound intensive care patients are moved within a hospital, the single most common risk factor is nonfunctioning technology and equipment. These transfers, a well-known moment of risk, have been studied in a University of Gothenburg thesis.
A quinic acid derivative, known as KZ-41, increases 30-day survival threefold compared with placebo when given to rats 24 hours after exposure to high levels of radiation.
As with any complex machine, sometimes a simple crossed wire or short circuit can cause problems with how it functions. The same goes for our brains, and even when the short circuit is uncovered, sometimes experts don't have a quick fix.
Aeterna Zentaris Inc. today announced that its Vice President, Alliance Management and Intellectual Property, Eckhard Guenther, Ph.D., will make a presentation on two of the Company's novel anticancer compounds, AEZS-108 and AEZS-129, at Bio Partnering North America on Monday, February 28, 2011, at 4 p.m. in the West Meeting Room 218, of the Vancouver Convention Center in Vancouver, Canada.
› Verified 1 days ago
| Entity Name | Martin A Morse Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366506172 PECOS PAC ID: 2466636568 Enrollment ID: O20231127001879 |
News Archive
When bedbound intensive care patients are moved within a hospital, the single most common risk factor is nonfunctioning technology and equipment. These transfers, a well-known moment of risk, have been studied in a University of Gothenburg thesis.
A quinic acid derivative, known as KZ-41, increases 30-day survival threefold compared with placebo when given to rats 24 hours after exposure to high levels of radiation.
As with any complex machine, sometimes a simple crossed wire or short circuit can cause problems with how it functions. The same goes for our brains, and even when the short circuit is uncovered, sometimes experts don't have a quick fix.
Aeterna Zentaris Inc. today announced that its Vice President, Alliance Management and Intellectual Property, Eckhard Guenther, Ph.D., will make a presentation on two of the Company's novel anticancer compounds, AEZS-108 and AEZS-129, at Bio Partnering North America on Monday, February 28, 2011, at 4 p.m. in the West Meeting Room 218, of the Vancouver Convention Center in Vancouver, Canada.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martin A Morse, MD, FACS Po Box 2043, Queen Creek, AZ 85142-1843 Ph: (703) 757-6190 | Dr Martin A Morse, MD, FACS 8841 E Bell Rd Ste 201, Scottsdale, AZ 85260-1984 Ph: (703) 757-6190 |
News Archive
When bedbound intensive care patients are moved within a hospital, the single most common risk factor is nonfunctioning technology and equipment. These transfers, a well-known moment of risk, have been studied in a University of Gothenburg thesis.
A quinic acid derivative, known as KZ-41, increases 30-day survival threefold compared with placebo when given to rats 24 hours after exposure to high levels of radiation.
As with any complex machine, sometimes a simple crossed wire or short circuit can cause problems with how it functions. The same goes for our brains, and even when the short circuit is uncovered, sometimes experts don't have a quick fix.
Aeterna Zentaris Inc. today announced that its Vice President, Alliance Management and Intellectual Property, Eckhard Guenther, Ph.D., will make a presentation on two of the Company's novel anticancer compounds, AEZS-108 and AEZS-129, at Bio Partnering North America on Monday, February 28, 2011, at 4 p.m. in the West Meeting Room 218, of the Vancouver Convention Center in Vancouver, Canada.
› Verified 1 days ago
Sumer Louise Daiza, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10900 N Scottsdale Rd, 603, Scottsdale, AZ 85254 Phone: 480-585-0011 | |
Dr. Paul Leo Schnur, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 8201 E Del Camino Dr, Scottsdale, AZ 85258 Phone: 480-443-8201 | |
Mrs. Kelly Anne Soares, PA-C Plastic Surgery Medicare: Medicare Enrolled Practice Location: 9819 N 95th St Ste 105, Scottsdale, AZ 85258 Phone: 480-874-2229 | |
Sergey Y Turin, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7301 E 2nd St Ste 202, Scottsdale, AZ 85251 Phone: 480-690-9153 | |
Danielle Anne Thornburg, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Mr. Andrew M Wolin, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3301 N Miller Rd, 140, Scottsdale, AZ 85251 Phone: 480-945-8440 Fax: 480-949-7976 | |
Dr. Erwin Alfonso Kruger, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 |